GXP PHARMAID ApS — Credit Rating and Financial Key Figures
CVR number: 29615861
Korsager Allé 9, 2700 Brønshøj
nasa@cgxp.eu
tel: 30916335
www.cgxp.eu
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 762.55 | 2 798.98 | 363.32 | 349.68 | 1 192.15 |
| Employee benefit expenses | - 880.41 | -1 558.62 | - 989.95 | - 734.50 | - 517.15 |
| Total depreciation | -12.62 | -16.85 | -15.02 | -9.91 | |
| EBIT | - 130.48 | 1 223.51 | - 641.65 | - 394.72 | 675.01 |
| Other financial income | 2.82 | 9.11 | 5.82 | 6.00 | |
| Other financial expenses | -33.51 | -34.78 | -11.30 | -21.57 | -22.45 |
| Pre-tax profit | - 163.99 | 1 191.55 | - 643.84 | - 410.47 | 658.55 |
| Income taxes | -4.99 | - 231.27 | 139.88 | 85.70 | - 145.39 |
| Net earnings | - 168.98 | 960.28 | - 503.96 | - 324.77 | 513.16 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Machinery and equipment | 41.78 | 24.93 | 9.91 | ||
| Tangible assets total | 41.78 | 24.93 | 9.91 | ||
| Investments total | 25.80 | 13.06 | 14.75 | 15.60 | |
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 544.22 | 6.95 | 142.07 | 780.09 | 635.87 |
| Current amounts owed by group member comp. | 114.71 | 191.37 | 197.19 | 203.19 | |
| Current other receivables | 189.91 | 83.81 | |||
| Current deferred tax assets | 3.96 | 2.30 | 139.88 | 225.58 | 80.19 |
| Short term receivables total | 548.18 | 313.87 | 557.13 | 1 202.86 | 919.25 |
| Cash and bank deposits | 782.84 | 2 632.07 | 449.07 | 27.97 | 763.19 |
| Cash and cash equivalents | 782.84 | 2 632.07 | 449.07 | 27.97 | 763.19 |
| Balance sheet total (assets) | 1 398.60 | 2 983.92 | 1 030.86 | 1 246.43 | 1 682.44 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 125.00 | 125.00 | 125.00 | 125.00 | 125.00 |
| Share premium account | 1 192.13 | 1 192.13 | 1 192.13 | ||
| Shares repurchased | 500.00 | ||||
| Retained earnings | - 413.18 | -1 082.16 | - 121.88 | 566.29 | 241.52 |
| Profit of the financial year | - 168.98 | 960.28 | - 503.96 | - 324.77 | 513.16 |
| Shareholders equity total | 734.97 | 1 695.25 | 691.29 | 366.52 | 879.68 |
| Non-current liabilities total | |||||
| Current trade creditors | 36.19 | 37.66 | 38.06 | 37.69 | 25.00 |
| Current owed to participating | 2.33 | 16.46 | 4.21 | 6.84 | 7.65 |
| Current owed to group member | 506.56 | 121.32 | 688.93 | 504.75 | |
| Short-term deferred tax liabilities | 243.72 | ||||
| Other non-interest bearing current liabilities | 118.55 | 990.83 | 175.99 | 146.46 | 265.37 |
| Current liabilities total | 663.63 | 1 288.68 | 339.57 | 879.92 | 802.76 |
| Balance sheet total (liabilities) | 1 398.60 | 2 983.92 | 1 030.86 | 1 246.43 | 1 682.44 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.